MedPath

ARO-APOC3

Generic Name
ARO-APOC3
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Background

ARO-APOC3 is an investigational RNAi therapeutic targeting apolipoprotein C-III (APOC3). It received an Orphan Drug designation by the FDA for the treatment of familial chylomicronemia syndrome.

Associated Conditions
-
Associated Therapies
-

Study of ARO-APOC3 in Adults With Dyslipidemia

Phase 2
Active, not recruiting
Conditions
Dyslipidemias
Interventions
First Posted Date
2022-06-09
Last Posted Date
2025-01-07
Lead Sponsor
Arrowhead Pharmaceuticals
Target Recruit Count
418
Registration Number
NCT05413135
Locations
🇺🇸

Westside Medical Associates of Los Angeles, Beverly Hills, California, United States

🇺🇸

Valley Clinical Trials; Inc., Northridge, California, United States

🇺🇸

Desert Medical Group, Inc., Palm Springs, California, United States

and more 57 locations
© Copyright 2025. All Rights Reserved by MedPath